Luo et al. have examined mRNA levels of ABH5 and FTO and noticed that the mRNA expression of these enzymes in patients with rheumatoid arthritis is significantly reduced compared to a control group; meanwhile, in patients who receive regular treatment, the level of ABH5 mRNA significantly went up [170]. This evidence concerns the gene ALKBH5 and rheumatoid arthritis.